title: Topoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivo.
abstract: The effect of SN-38 was evaluated on multiple lung cancer cell lines. It inhibits anchorage-dependent and -independent growth as monitored by MTT and soft agar colony assay, respectively. SN-38 collapsed the mitochondrial membrane potential (MMP), arrested cells in S- and G2-phases of the cell cycle, and induced apoptosis via activation of caspase 3 and PARP. A single injection of 2 mg/kg body weight of SN-38 caused a significant reduction of lung cancer xenografts. These findings indicate that SN-38 induces apoptosis in the lung cancer cells effectively. Thus, SN-38 can potentially be an effective therapeutic agent against lung cancer.
authors: Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.
authors: Dharmendra Kumar
authors: DK
authors: Maurya
authors: Rie
authors: R
authors: Ayuzawa
authors: Chiyo
authors: C
authors: Doi
authors: Deryl
authors: D
authors: Troyer
authors: Masaaki
authors: M
authors: Tamura
references: Br J Cancer. 1998 Jun;77(12):2171-6
references: 9649129
references: Anticancer Drugs. 1997 Mar;8(3):231-7
references: 9095327
references: Oncogene. 2002 Dec 12;21(57):8786-803
references: 12483532
references: J Natl Cancer Inst. 1991 Jun 19;83(12):855-61
references: 1648142
references: Br J Cancer. 1999 Dec;81(8):1285-93
references: 10604724
references: Curr Med Chem. 2003 Dec;10(23):2549-58
references: 14529470
references: Cancer Chemother Biol Response Modif. 2002;20:763-86
references: 12703233
references: N Engl J Med. 2002 Jan 10;346(2):85-91
references: 11784874
references: Toxicol In Vitro. 2001 Aug-Oct;15(4-5):265-70
references: 11566547
references: BMC Pharmacol. 2005 Jun 20;5:11
references: 15963241
references: Cancer. 1991 Nov 1;68(9):1973-7
references: 1655232
references: Oncogene. 2004 Sep 2;23(40):6702-11
references: 15273734
references: Lancet. 2000 Mar 25;355(9209):1041-7
references: 10744089
references: N Engl J Med. 2004 Jun 3;350(23):2335-42
references: 15175435
references: Biophys J. 1999 Jan;76(1 Pt 1):469-77
references: 9876159
references: J Clin Oncol. 1992 Aug;10(8):1225-9
references: 1321891
references: Cancer Res. 1991 Aug 15;51(16):4187-91
references: 1651156
references: J Clin Oncol. 1996 Feb;14(2):658-65
references: 8636784
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: Blood. 2001 Nov 1;98(9):2603-14
references: 11675328
references: Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4199s-4204s
references: 15217958
references: Nature. 2000 Oct 12;407(6805):770-6
references: 11048727
references: J Biol Chem. 1985 Nov 25;260(27):14873-8
references: 2997227
references: J Clin Oncol. 1992 Feb;10(2):282-91
references: 1310103
references: Cell Death Differ. 2002 Oct;9(10):1031-42
references: 12232790
references: Annu Rev Physiol. 1998;60:619-42
references: 9558479
references: Cancer Res. 1996 Feb 15;56(4):794-801
references: 8631016
references: J Biol Chem. 1998 May 29;273(22):13703-12
references: 9593711
references: Radiat Res. 1985 Jan;101(1):4-15
references: 3155867
references: Carcinogenesis. 2000 Mar;21(3):485-95
references: 10688869
references: J Transl Med. 2005 Dec 23;3:44
references: 16375766
references: N Engl J Med. 1992 Nov 12;327(20):1434-41
references: 1328881
references: Lung Cancer. 2003 Aug;41(2):187-98
references: 12871782
references: Neoplasia. 2005 Feb;7(2):162-70
references: 15802021
references: Nature. 1995 Jul 6;376(6535):37-43
references: 7596430
references: Cancer Res. 1988 Apr 1;48(7):1722-6
references: 2832051
references: Cancer Lett. 2004 May 28;208(2):163-70
references: 15142674
references: Cancer Res. 2007 Apr 15;67(8):3512-7
references: 17440056
references: Carcinogenesis. 2001 Aug;22(8):1111-7
references: 11470738
references: Cancer Sci. 2008 Jun;99(6):1258-64
references: 18429960
references: Oncol Rep. 2008 Jun;19(6):1493-8
references: 18497955